Journal article
The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer
M Alamgeer, V Ganju, A Szczepny, PA Russell, Z Prodanovic, B Kumar, Z Wainer, T Brown, M Schneider-Kolsky, M Conron, G Wright, DN Watkins
Thorax | BMJ PUBLISHING GROUP | Published : 2013
Abstract
Background Expression of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 has been functionally associated with a stem cell phenotype in normal and malignant cells. The prevalence of such cells in solid tumours should therefore correlate with recurrence and/ or metastasis following definitive surgical resection. The aim of this study was to evaluate the prognostic significance of ALDH1A1 and CD133 in surgically resected, early stage non-small cell lung cancer (NSCLC). Methods A retrospective analysis of ALDH1A1 and CD133 expression in 205 patients with pathologic stage I NSCLC was performed using immunohistochemistry. The association between the expression of both markers and survival was dete..
View full abstractGrants
Funding Acknowledgements
This work was supported by the Victorian Cancer Agency, the National Health and Medical Research Council of Australia and the Victorian Government Operational Infrastructure Support Program.